Roche offloads lebrikizumab to Dermira

15:40 EDT 10 Aug 2017 | Elsevier Business Intelligence

Roche and its Genentech Inc. division licensed Dermira Inc. exclusive global development and commercialization rights to thei...

Original Article: Roche offloads lebrikizumab to Dermira


More From BioPortfolio on "Roche offloads lebrikizumab to Dermira"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...